Literature DB >> 2899075

Regulation of the proliferating cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors.

D Jaskulski1, C Gatti, S Travali, B Calabretta, R Baserga.   

Abstract

The enzymes of the DNA synthesizing machinery constitute a group of gene products that are generally expressed co-ordinately at the G1/S boundary of the cell cycle. We have investigated how growth factors regulate the steady-state mRNA levels of two of these genes, the PCNA (proliferating cell nuclear antigen)/cyclin and the thymidine kinase genes. To detect the PCNA/cyclin mRNA, we isolated a cDNA clone from a human library. Two different cell lines were used for these studies: BALB/c3T3 cells, which are exquisitely sensitive to growth factors, and ts13 cells, a temperature-sensitive (ts) mutant of the cell cycle, which arrests in G1 at the restrictive temperature. The steady-state levels of the RNAs for these two genes under different growth conditions were also compared with the levels of histone H3 RNA which are good indicators of the fraction of cells in S phase. Both PCNA/cyclin and thymidine kinase genes share two fundamental characteristics, i.e. they are not inducible in a G1-specific ts mutant of the cell cycle at the restrictive temperature and their expression is inhibited by cycloheximide, indicating that unlike early growth-regulated genes, they require the previous expression of other growth-regulated genes. However, the two genes also show differences, the most notable being that PCNA/cyclin is inducible by epidermal growth factor alone, while thymidine kinase is not.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2899075

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase.

Authors:  D Lin; M T Shields; S J Ullrich; E Appella; W E Mercer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

2.  The role of the promoter in the expression of the PCNA gene.

Authors:  R H Charollais; H Alder; A Ferber; J Koniecki; C Sell; R Baserga
Journal:  Gene Expr       Date:  1992

3.  Identification and characterization of a noncoding RNA at the mouse Pcna locus.

Authors:  Ji-Yeon Lee; Abdul Aziz Khan; Hyehyun Min; Xinnan Wang; Myoung Hee Kim
Journal:  Mol Cells       Date:  2012-01-02       Impact factor: 5.034

4.  Upstream sequences of rice proliferating cell nuclear antigen (PCNA) gene mediate expression of PCNA-GUS chimeric gene in meristems of transgenic tobacco plants.

Authors:  S Kosugi; I Suzuka; Y Ohashi; T Murakami; Y Arai
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

5.  Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression.

Authors:  W E Mercer; M T Shields; D Lin; E Appella; S J Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

6.  Activation of muscarinic acetylcholine receptors inhibits cell cycle progression of small cell lung carcinoma.

Authors:  C L Williams; V A Lennon
Journal:  Cell Regul       Date:  1991-05

Review 7.  Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells.

Authors:  Yohei Maeshima
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

8.  Intracellular interleukin 6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells.

Authors:  M Roth; M Nauck; M Tamm; A P Perruchoud; R Ziesche; L H Block
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

9.  Molecular analysis of p53 gene in laryngeal premalignant and malignant lesions. p53 protein immunohistochemical expression is positively related to proliferating cell nuclear antigen labelling index.

Authors:  V Gorgoulis; V Zoumpourlis; G Rassidakis; A Karameris; C Barbatis; D A Spandidos; C Kittas
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.

Authors:  M Thomas; M Noguchi; H Kitagawa; K Kinoshita; I Miyazaki
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.